Oklo stock tumbles as Financial Times scrutinizes valuation
Vital Farms, Inc. (NASDAQ:VITL), a $1.94 billion market cap company showing strong revenue growth of ~21% over the last twelve months, reported that President and CEO Diez-Canseco Russell sold 9,667 shares of common stock on October 8, 2025, in two separate transactions, with the total transactions amounting to $429,097. According to InvestingPro analysis, the company maintains excellent financial health with more cash than debt on its balance sheet.
The prices for the shares sold ranged from $43.46 to $45.09. Following the transactions, Diez-Canseco directly owns 666,109 shares of Vital Farms, Inc.
The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 12, 2025.
In other recent news, Vital Farms has seen several updates from analysts regarding its stock price targets and ratings. DA Davidson has reiterated its Buy rating, emphasizing a positive outlook as supply and capacity constraints ease. TD Cowen has increased its price target for Vital Farms to $59, attributing the change to factors such as distribution growth and rising consumer awareness. Similarly, BMO Capital has raised its price target to $60 after discussions with company leadership about growth potential in the U.S. pasture-raised egg market. Mizuho has also increased its price target to $53, citing improvements in the supply chain and confidence in meeting future sales targets. DA Davidson has further adjusted its price target to $52, noting that inventory issues are lessening, and consumer awareness is on the rise due to enhanced advertising efforts. These developments reflect a broadly positive sentiment from analysts regarding Vital Farms’ future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.